capivasertib,AZD5363
astrazeneca,otsuka
['bcsm']
#faktion by dr. jones: akt doubles pfs when added to fulvestrant 4.8 to 10.3 mo. os improved from 23 to 29 months, hr 0.66. benefit regardless of pathway alterations. #asco22 #bcsm 
Med Onc, Director of Breast & GYN Research Program @ Sarah Cannon Research Institute #bcsm #gyncsm #WomenInMedicine USAF Wife, Mom to 2 girls, tweets are mine.